ArthroCare (NASDAQ: ARTC) reported Q2 EPS of $0.30, $0.10 worse than the analyst estimate of $0.40. Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE